VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 189 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $30,000 | -9.1% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $33,000 | -2.9% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $34,000 | -27.7% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $47,000 | -7.8% | 3,000 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $51,000 | -21.5% | 3,000 | 0.0% | 0.00% | -20.0% |
| Q2 2021 | $65,000 | -13.3% | 3,000 | -40.0% | 0.01% | -28.6% |
| Q1 2021 | $75,000 | +13.6% | 5,000 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $66,000 | +37.5% | 5,000 | 0.0% | 0.01% | +16.7% |
| Q3 2020 | $48,000 | -15.8% | 5,000 | 0.0% | 0.01% | -14.3% |
| Q2 2020 | $57,000 | +9.6% | 5,000 | 0.0% | 0.01% | -12.5% |
| Q1 2020 | $52,000 | -36.6% | 5,000 | 0.0% | 0.01% | -11.1% |
| Q4 2019 | $82,000 | +24.2% | 5,000 | 0.0% | 0.01% | +28.6% |
| Q3 2019 | $66,000 | -28.3% | 5,000 | 0.0% | 0.01% | -36.4% |
| Q1 2019 | $92,000 | -29.8% | 5,000 | 0.0% | 0.01% | -35.3% |
| Q4 2018 | $131,000 | +13.9% | 5,000 | 0.0% | 0.02% | +30.8% |
| Q3 2018 | $115,000 | +21.1% | 5,000 | 0.0% | 0.01% | +18.2% |
| Q2 2018 | $95,000 | +13.1% | 5,000 | 0.0% | 0.01% | +10.0% |
| Q1 2018 | $84,000 | +10.5% | 5,000 | 0.0% | 0.01% | +11.1% |
| Q4 2017 | $76,000 | -15.6% | 5,000 | 0.0% | 0.01% | -18.2% |
| Q3 2017 | $90,000 | +9.8% | 5,000 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $82,000 | +17.1% | 5,000 | 0.0% | 0.01% | +10.0% |
| Q1 2017 | $70,000 | -12.5% | 5,000 | 0.0% | 0.01% | -16.7% |
| Q4 2016 | $80,000 | -3.6% | 5,000 | 0.0% | 0.01% | -20.0% |
| Q3 2016 | $83,000 | +48.2% | 5,000 | 0.0% | 0.02% | +50.0% |
| Q2 2016 | $56,000 | +33.3% | 5,000 | 0.0% | 0.01% | +25.0% |
| Q1 2016 | $42,000 | -10.6% | 5,000 | 0.0% | 0.01% | -11.1% |
| Q4 2015 | $47,000 | -16.1% | 5,000 | 0.0% | 0.01% | -25.0% |
| Q3 2015 | $56,000 | -11.1% | 5,000 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $63,000 | +37.0% | 5,000 | 0.0% | 0.01% | +33.3% |
| Q1 2015 | $46,000 | -36.1% | 5,000 | 0.0% | 0.01% | -35.7% |
| Q4 2014 | $72,000 | +38.5% | 5,000 | 0.0% | 0.01% | +40.0% |
| Q3 2014 | $52,000 | -35.8% | 5,000 | 0.0% | 0.01% | -37.5% |
| Q2 2014 | $81,000 | 0.0% | 5,000 | 0.0% | 0.02% | -5.9% |
| Q1 2014 | $81,000 | – | 5,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |